125 related articles for article (PubMed ID: 8978367)
1. Nonmitogenic actions of growth factors: an integrated view of their role in intestinal physiology and pathophysiology.
Uribe JM; Barrett KE
Gastroenterology; 1997 Jan; 112(1):255-68. PubMed ID: 8978367
[No Abstract] [Full Text] [Related]
2. Altered gene expression of growth factors and their receptors during esophageal tumorigenesis.
Jankowski J
Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D40-5. PubMed ID: 8013782
[No Abstract] [Full Text] [Related]
3. Roles of transforming growth factor-alpha and epidermal growth factor in chick limb development.
Dealy CN; Scranton V; Cheng HC
Dev Biol; 1998 Oct; 202(1):43-55. PubMed ID: 9758702
[TBL] [Abstract][Full Text] [Related]
4. Effect of human milk and recombinant EGF, TGFalpha, and IGF-1 on small intestinal cell proliferation.
Wagner CL; Forsythe DW
Adv Exp Med Biol; 2000; 478():373-4. PubMed ID: 11065088
[No Abstract] [Full Text] [Related]
5. [The (patho)physiological significance of epidermal growth factor in relation to antisecretory, cytoprotective and mitogenic effects in the digestive tract].
van den Hoek MC; Pronk JC; Eriksson AW; Meuwissen SG
Ned Tijdschr Geneeskd; 1989 Sep; 133(38):1873-6. PubMed ID: 2677795
[No Abstract] [Full Text] [Related]
6. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology.
Barnard JA; Beauchamp RD; Russell WE; Dubois RN; Coffey RJ
Gastroenterology; 1995 Feb; 108(2):564-80. PubMed ID: 7835600
[No Abstract] [Full Text] [Related]
7. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells.
Romano M; Ricci V; Di Popolo A; Sommi P; Del Vecchio Blanco C; Bruni CB; Ventura U; Cover TL; Blaser MJ; Coffey RJ; Zarrilli R
J Clin Invest; 1998 Apr; 101(8):1604-13. PubMed ID: 9541490
[TBL] [Abstract][Full Text] [Related]
8. EGF, TGF alpha, AR and HB-EGF are autocrine growth factors for human bladder carcinoma cell lines.
Ruck A; Paulie S
Anticancer Res; 1998; 18(3A):1447-52. PubMed ID: 9673354
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides.
Normanno N; Bianco C; Damiano V; de Angelis E; Selvam MP; Grassi M; Magliulo G; Tortora G; Bianco AR; Mendelsohn J; Salomon DS; Ciardiello F
Clin Cancer Res; 1996 Mar; 2(3):601-9. PubMed ID: 9816209
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of chick lens epithelial cells: involvement of the epidermal growth factor receptor and endogenous ligand.
Ireland ME; Mrock LK
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):183-90. PubMed ID: 10634619
[TBL] [Abstract][Full Text] [Related]
11. [Cellular aging and growth factor].
Kaji K
Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1300-9. PubMed ID: 1871354
[No Abstract] [Full Text] [Related]
12. Role of epidermal growth factor and its receptor in chemotherapy-induced intestinal injury.
Huang FS; Kemp CJ; Williams JL; Erwin CR; Warner BW
Am J Physiol Gastrointest Liver Physiol; 2002 Mar; 282(3):G432-42. PubMed ID: 11841993
[TBL] [Abstract][Full Text] [Related]
13. The role of transforming growth factor alpha in determining growth factor independence.
Awwad RA; Sergina N; Yang H; Ziober B; Willson JK; Zborowska E; Humphrey LE; Fan R; Ko TC; Brattain MG; Howell GM
Cancer Res; 2003 Aug; 63(15):4731-8. PubMed ID: 12907656
[TBL] [Abstract][Full Text] [Related]
14. Common behavioral influences of the ErbB1 ligands transforming growth factor alpha and epiregulin administered to mouse neonates.
Tsuda N; Mizuno M; Yamanaka T; Komurasaki T; Yoshimoto M; Nawa H
Brain Dev; 2008 Sep; 30(8):533-43. PubMed ID: 18313247
[TBL] [Abstract][Full Text] [Related]
15. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
[TBL] [Abstract][Full Text] [Related]
16. [New approaches to antitumor therapy: the use of preparations acting on processes regulated by epidermal and/or alpha-transforming growth factors].
Kushlinskiĭ NE; Gershteĭn ES
Eksp Klin Farmakol; 1996; 59(1):74-80. PubMed ID: 8704642
[No Abstract] [Full Text] [Related]
17. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in labial salivary glands in Sjögren's syndrome.
Koski H; Konttinen YT; Hietanen J; Tervo T; Malmström M
J Rheumatol; 1997 Oct; 24(10):1930-5. PubMed ID: 9330934
[TBL] [Abstract][Full Text] [Related]
18. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
[TBL] [Abstract][Full Text] [Related]
19. [The expression and their significance of epidermal growth factor, transforming growth factor alpha and epidermal growth factor receptor during the intrahepatic cholangiocarcinoma carcinogenesis].
Zhuang DY; Liang P; Fan XH; Chen H
Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):55. PubMed ID: 14761293
[No Abstract] [Full Text] [Related]
20. Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: lower EGF receptor affinity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis.
Thoresen GH; Guren TK; Sandnes D; Peak M; Agius L; Christoffersen T
J Cell Physiol; 1998 Apr; 175(1):10-8. PubMed ID: 9491776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
